References
- Braunwald E. Normal and abnormal myocardial function. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, eds. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill, 1994: 989–98
- Braunwald E. Heart failure. In: Isselbacher et al, eds,1 pp 998–1009
- Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med 1992; 117(6): 502–10
- Coats AJ, Adamopoulos S, Meyer TE, et al. Effects of physical training in chronic heart failure. Lancet 1990; 335(8681): 63–6
- Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314(24): 1547–52
- Cohn JN, Johnson G, Ziesche J, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325(5): 303–10
- Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. (Editorial) J Am Coll Cardiol 1992; 20(1): 248–54
- Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med 1991: 325(21): 1468–75
- Greene HL. Clinical significance and management of arrhythmias in the heart failure patient. Clin Cardiol 1992; 15(Suppt 1): I13–21
- The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327(10): 685–91 [Erratum, N Engl J Med 1992; 327(24): 1768]
- Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327(10): 669–77
- Waagstein F, Caidahl K, Wallentin I, et al. Long-term beta-blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989; 80(3): 551–63
- Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993; 342(8885): 1441–6
- CIBIS Investigators and Committees. A randomized trial of beta blockade in heart failure. Circulation 1994; 90(4): 1765–73
- Hall D, Zeider H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992; 20(7): 1549–55
- Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol 1989; 63(7): 461–4
- Schroeder JS, Gao SZ, Alderman EL, et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 1993; 328(3): 164–70
- US Department of Health and Human Services. Heart failure: management of patients with left-ventricular systolic dysfunction. Rockville, Md: Agency for Health Care Policy and Research, 1994; AHCPR publication No. 94–0613 (call toll-free 800–358-9295)